Immune Checkpoint Inhibition
2 clinical trials · Condition
◉ Watch Immune Checkpoint Inhibition
| Record | Firm | Date |
|---|---|---|
| Camrelizumab Combined With Apatinib in the Treatment of Epithelial Ovarian Cancer (NCT04507750) | Qianfoshan Hospital | 2020-08-10 |
| REACTION (Radiation Enhanced Assessment of Combination Therapies in Immuno-ONcology) - Nivolumab or Nivolumab in Combination With Other Immuno-oncology (IO) Agents After Targeted Systemic Radiation in Patients With Advanced Esophagogastric Cancer (NCT03610711) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2019-03-06 |
Track Immune Checkpoint Inhibition automatically
Every clearance here is in the API, with alerts when new ones post.